NCT02911870View on ClinicalTrials.gov

A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

84

Participants

Timeline

Start Date

September 23, 2016

Primary Completion Date

May 4, 2017

Study Completion Date

May 11, 2017

Conditions

Healthy

Interventions

DRUG

SNAC

Oral administration

DRUG

Placebo

Oral administration

DRUG

Moxifloxacin

Oral administration

Trial Locations (1)

14050

Novo Nordisk Investigational Site, Berlin

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY